Diversifying When You Have Worth Stock: Tax-Smart Moves
A rising share of investors with concentrated positions are turning to tax-aware diversification as market conditions...
Articles — Page 32
Millennials Banking Inheritance Can’t Rely on Mom and Dad
A growing share of millennials can’t rely on inheritances to fund retirement, as gifts arrive later in life and may n...
Goldman Sachs Exits XRP and SOL ETF Positions in Q1 2026
Goldman Sachs exited all XRP and SOL ETF positions in Q1 2026, according to the latest 13F filing. The move shifts th...
Dominion Energy Stock Jumped: What Investors Should Know
A landmark deal sent Dominion Energy stock jumped after NextEra Energy offered a stock-for-stock combination. This ar...
I’m with $6,000 Debt: Should I Invest Now or Pay It Down?
Young earners face a tough choice: invest now or aggressively repay debt. This report explains the math, the Baby Ste...
Fund Exited Polaris Company: Fundamentals Drive the Move
When investors decide to exit Polaris Company, the choice hinges on solid fundamentals and disciplined portfolio math...
Forest Avenue Capital Adds to Par Pacific Stake: A Deep Dive
A quiet SEC filing reveals a larger stake in Par Pacific. Explore what forest avenue capital adds means for investors...
Semiconductor Exposure Hits 18% of S&P 500 This Year
The S&P 500 now carries an 18% semiconductor exposure, a level unseen since the dot-com era. A handful of chipmakers ...
Deal Restores the Nation’s Busiest Commuter Railroad
The nation’s busiest commuter railroad will restart in phased steps after a strike ends, with riders returning to reg...
Investment Banker Reveals Pension: Why 60/40 Wins Over Complex Funds
An experienced investment banker explains why pension funds stick with complex alternatives even when a simple 60/40 ...
WaterBridge Stock Since IPO Surges 55% Amid Big Fund Buy
WaterBridge stock since IPO has surged about 55% as institutional investors push deeper into water management for ene...
Lilly Stock: Next Stop — Can Lilly Stock Reach $2,000?
Investors are watching Lilly stock: next stop as the company leverages obesity and diabetes drugs, while facing risin...